Early research (Phase 1)Study completedNCT02783300
What this trial is testing
An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma
Who this might be right for
Neoplasms
GlaxoSmithKline 297